Zealand Pharma A/S (ZEAL) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $29.00 (low: $26.00, high: $32.00), representing an upside of 64.9% from the current price $17.59.
ZEAL Stock — 12-Month Price Forecast
$29.00
▲ +64.87% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Zealand Pharma A/S, the average price target is $29.00, with a high forecast of $32.00, and a low forecast of $26.00.
The average price target represents a +64.87% change from the last price of $17.59.
Highest Price Target
$32.00
Average Price Target
$29.00
Lowest Price Target
$26.00
ZEAL Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Zealand Pharma A/S in the past 3 months
